Search En menu ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages
    Reference: 20190318
    Release date: 31 March 2020

    Promoter – Financial Intermediary

    AM-PHARMA HOLDING B.V.

    Location

    Description

    The Promoter is a Dutch biopharmaceutical company developing a proprietary enzyme that has the potential to transform the treatment prospects for patients with sepsis-induced conditions, such as Sepsis-Associated Acute Kidney Injuries (SA-AKI).

    Objectives

    The proposed transaction will support R&D investments required to bring a product to the market addressing a high unmet medical need, in a growing patient population, preserving and cultivating highly skilled employment opportunities.

    Sector(s)

    • Services - Professional, scientific and technical activities

    Proposed EIB finance (Approximate amount)

    EUR 24 million

    Total cost (Approximate amount)

    EUR 49 million

    Environmental aspects

    The project mainly concerns investments in research and development (R&D) that are expected to be carried out in existing facilities already authorised for the same purpose and would therefore not require an Environmental Impact Assessment (EIA) under Directive 2014/52/EU amending the Directive 2011/92/EC. However, full environmental details will be verified during appraisal.

    Procurement

    The promoter has been assessed by EIB as being a private company not operating in the utilities sector and not having a status of a contracting entity, thus not being subject to EU rules on public procurement. However, if after the project appraisal, the EIB were to conclude that the promoter is after all subject to EU public procurement legislation (i.e. Directive 2014/24/EU), then the Bank would require the promoter to ensure that contracts for the implementation of the project will be tendered in accordance with the relevant applicable EU procurement legislation (Directive 2014/24/EU and Directive 89/665/EEC), with publication of tender notices in the EU Official Journal, as and where required.

    Status

    Signed - 19/12/2019

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Related tags

    The Netherlands Services